Concepedia

Economic evaluation of second generation pneumococcal conjugate vaccines in Norway

Bjarne Robberstad, Carl Richard Frostad, Per Espen Akselsen, Kari Jorunn Kværner, Aud Katrine Herland Berstad

Vaccine · 2011 · 37 citations · 37 references

DOI

Concepts

References

37

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

Steven Black, Henry R. Shinefield, Bruce Fireman et al. · The Pediatric Infectious Disease Journal · 2000 · 2.3K citations

, , +17

Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

Juhani Eskola, Terhi Kilpi, Arto A. Palmu et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

, , +17

Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions

Elisabeth Fenwick, Bernie J. OʼBrien, Andrew Briggs · Health Economics · 2004 · 943 citations

, , +16

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · The Lancet · 2006 · 640 citations

, , +16

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Cynthia G. Whitney, Tamar Pilishvili, Monica M. Farley et al. · The Lancet · 2006 · 625 citations · Full text

, , +16